Tags: mCRPC
Highlights in Prostate Cancer From the 2020 American Society of Clinical Oncology Annual Meeting
May 29-31, 2020 • Virtual 68Ga-PSMA-11 PET Has Poor Sensitivity, Good Specificity for Pelvic Nodal Metastases 68Ga-PSMA-11 positron emission tomography (PET) has poor sensitivity and […]
Treatment Options for Patients With Prostate Cancer Who Develop Metastatic Disease After Hormonal Therapy
Case The patient is a 66-year-old man in good cardiovascular health. He has a family history of prostate cancer. He presents with fatigue and minor […]
Optimal Use of Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
H&O What is the treatment protocol for patients with mCRPC? DG An exciting aspect of the field today is that there are many options for the […]